Bimbam (@Klambam) na getquin

Bimbam

@Klambam

1Ano·

Has anyone read news about $IBRX (+1,2%) or knows what is going on? Almost 300% in one month.

11 Comentários

Patrick ₿ateman@fastlane

1Ano

„NATIONAL MULTICENTER TRIAL OPENS TO STUDY IMMUNITYBIO'S TRI-AD5 CANCER
VACCINES PLUS N-803 TO PREVENT CANCER IN PEOPLE WITH LYNCH SYNDROME“ - Reuters

•

Yassin@RisingAktie

1Ano

Wanted to expand my position the other day when they were at just under € 2, but then they were already slowly shooting up again. Stupid timing until the money was on deposit :(

•

Ver todas as 3 restantes respostas

Nico@itZNico

1Ano

"The increase in share prices is likely due to the positive momentum building around the company's lead pipeline candidate, N-803. The FDA is currently reviewing a regulatory submission for N-803 in combination with Bacillus Calmette-Guerin (BGC) for the treatment of patients with bladder cancer." Source: https://www.zacks.com/stock/news/2091284/immunitybio-ibrx-stock-jumps-432-will-it-continue-to-soar

•

Bimbam@Klambam

1Ano

@Clermit that did not run with as hoped. rebuy? 😂

•

Mostrar resposta

MarsEquities@CircusClown

1Ano

What the others have already mentioned + general strength in biotech in recent weeks + insider buying in April by Soon-Shiong. IBRX was also sold off massively before that. YTD it is still "only" 22% up.

••

Ver todas as 2 restantes respostas